Form 3 Filing for LISATA THERAPEUTICS, INC.

This filing is an initial report of securities ownership (Form 3) for Ted W. Love, a director at LISATA THERAPEUTICS, INC. (LSTA). The report details holdings following a merger with Marea Therapeutics, Inc., where Mr. Love received shares of LISATA's Common Stock and Series C Non-Voting Convertible Preferred Stock. The Series C Preferred Stock is convertible into Common Stock upon stockholder approval, subject to beneficial ownership limitations. A portion of the reported shares are subject to the issuer's repurchase rights. The filing also includes a Power of Attorney document, authorizing representatives to execute and file necessary SEC forms on behalf of Mr. Love. The effective date of the merger and period of report is September 17, 2026. The signature date on the Power of Attorney is September 10, 2026, and the filing execution date is September 28, 2026.